About/Jdrf/Des Moines/Prevent Diabetes
The Health Care and Social Assistance industry includes establishments and services such as:
hospitals, nursing and residential care facilities and out-patient care centres; offices of health practitioners (i.e. dentists, doctors, optometrists and chiropractors); medical and diagnostic laboratories; home health care services; ambulance services; social assistance services (i.e. for children, youth, the elderly, families); community food, housing, emergency and relief services; vocational rehabilitation services; and daycare services JDRF works towards a day when there is no more type 1 diabetes. Type 1 diabetes is usually diagnosed in children and young adults, and was previously known as juvenile diabetes. In type 1 diabetes, the body does not produce insulin. Diabetes – is a problem with your body that causes blood glucose (sugar) levels to rise higher than normal. This is also called hyperglycemia. When you eat your body breaks food down into glucose and sends it into the blood. Insulin then helps move the glucose from the blood into your cells. When glucose enters your cells, it is either used as fuel for energy right away or stored for later use. In a person with diabetes, there is a problem with insulin. But, not everyone with diabetes has the same problem. There are different types of diabetes – type 1, type 2, and a condition called gestational diabetes, which happens during pregnancy. If you have diabetes, your body either doesn’t make enough insulin, it can’t use the insulin it does make very well, or both. Since its founding more than 40 years ago by parents of children affected by type 1 diabetes, the Juvenile Diabetes Research Foundation (JDRF) has been committed to finding a cure for all those individuals living with the disease. Today, JDRF acknowledges that this commitment will not likely be fulfilled in the near term. Although our ultimate goal—curing type 1 diabetes—remains unchanged, we are equally committed to better treating and preventing the disease. These goals aim to ensure that both children and adults living with type 1 diabetes remain healthy so that they can fully benefit from a cure when it becomes available. JDRF focuses on supporting the development and delivery of new therapies and devices that will ease the daily burden and challenges of managing type 1 diabetes and on the prevention of diabetes complications. Additionally, to protect future generations from developing type 1 diabetes, JDRF is supporting approaches to prevent the disease. All Video Credits you can find here http://broadcaster.beazil.net/public/credits/youtube/videos/42326 The City of Des Moines traces its origins to May 1843, when Captain James Allen supervised the construction of a fort on the site where the Des Moines and Raccoon Rivers merge. Allen wanted to use the name Fort Raccoon; however, the U.S. War Department told him to name it Fort Des Moines. The fort was built to control the Sauk and Meskwaki Indians, who had been transplanted to the area from their traditional lands in eastern Iowa. The fort was abandoned in 1846 after the Sauk and Meskwaki were removed from the state. JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
It is important to note the main points –
World diabetes day,Research Pathways,subcutaneous injection,prevention of complications,JDRF lobbies,diabetes mellitus,Understanding Type 1,very-low-density lipoprotein cholesterol,diabetic retinopathy,funding,Clinical Trials,charity,ketonuria,fasting plasma glucose,IGT,sulfonylurea,Government Advocacy,Insulin Pump Therapy,Research Funding,Des Moines,Afrezza,turn Type One into Type Now,Sodium–glucose cotransporter 2 inhibitors,The Ride to Cure Diabetes,insulin adjustment,blood glucose level,diabetes symptoms,IA,prevention,Children’s Congress,FPG value,Diabetes Complication,maturity-onset diabetes of the young,City of Skywalks,JDRFCC,diabetes death rate,adult-onset diabetes,acarabose,oral hypoglycemic agents,Grant Management Portal,American Diabetes Association,Bolus Basel,Stoke,Type 2 Diabetes,fundraising,impaired glucose tolerance,Treatment Advocacy,Derek Rapp,blindness,CDE,Food insecurity (FI),sugar breakdown,care delivery systems,metformin,diabetes insipidus,thiazolidinedione,PIs,bariatric surgery,blood pressure,show.